RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,724 | +22.0% | 112,908 | +0.0% | 0.09% | +12.5% |
| Q2 2023 | $277,729 | +18.0% | 112,898 | +8.4% | 0.08% | +9.6% |
| Q1 2023 | $235,356 | -17.1% | 104,140 | +28.0% | 0.07% | -8.8% |
| Q4 2022 | $283,953 | -26.6% | 81,362 | +678.0% | 0.08% | -23.1% |
| Q3 2022 | $387,000 | – | 10,458 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |